Evidence map›Paper›PMID 38510554›Full record

ReviewAmerican heart journal plus : cardiology research and practice2023

A review of the impact, pathophysiology, and management of atrial fibrillation in patients with heart failure with preserved ejection fraction.

Cicely Dye, Mark Dela Cruz, Timothy Larsen, Gatha Nair, Karolina Marinescu, Tisha Suboc, Erica Engelstein, Jennifer Marsidi, Priya Patel, Parikshit Sharma and 1 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in American heart journal plus : cardiology research and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Cicely DyeDivision of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA.
Mark Dela CruzAdvocate Heart Institute, Advocate Christ Medical Center, Chicago, IL 60453, USA.
Timothy LarsenDivision of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA.
Gatha NairDivision of Cardiology, University of Washington, Seattle, WA 98105, USA.
Karolina MarinescuDivision of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA.
Tisha SubocDivision of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA.
Erica EngelsteinDivision of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA.
Jennifer MarsidiDivision of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA.
Priya PatelDivision of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA.
Parikshit SharmaDivision of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA.
Annabelle Santos VolgmanDivision of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA.
Rush University Medical Center · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) have increased mortality and increased risk of stroke. Due to the heterogeneous nature of both disease processes, it is difficult to ascertain whether the diagnosis and progression of AF is the cause of deterioration or if it is a symptom of worsening heart failure. This presents physicians with a clinical conundrum of whether optimizing their heart failure will decrease the overall AF burden or if restoration of sinus rhythm is necessary to optimize patients with HFpEF. In this paper, we will review the impact of AF in patients with HFpEF, the pathophysiology and heterogeneity of HFpEF and AF, and the management of these patients. As HFpEF and AF become more prevalent, managing these disease processes needs standardization to improve outcomes. Further research is needed to understand the complex interplay between AF and HFpEF to help determine the best management strategy.

Indexed as

AnticoagulationAtrial fibrillationHeart failurePreserved ejection fractionRhythm control

Identifiers

PMID38510554
PMCPMC10946048
OpenAlexW4384699992

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.